MedTrace Logo

NSAA NON-Interventional Study Protocol

NCT06054971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2025-03-21

No results posted yet for this study

Summary

The purpose of this non-interventional study is to evaluate the feasibility of remotely administering the North Star Ambulatory Assessment (NSAA) to participants with Duchenne muscular dystrophy (DMD). The iTakeControl (iTC) software platform will be utilized to remotely administer and score the NSAAs.

Conditions

Interventions

OTHER

Remote Administration of NSAA

Remote Administration of NSAA

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Red Nucleus Enterprise Solutions, LLC

    lead INDUSTRY

Eligibility

Min Age
4 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-02
Primary Completion
2025-02-03
Completion
2025-03-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06054971 on ClinicalTrials.gov